Japan-US Research Collaboration on the Development of a Novel Therapeutic Strategy Targeting the Cancer-Associated Extracellular Components to Disrupt Cancer Progression

• Project/Area Number: 24KK0166
• Research Category: Fund for the Promotion of Joint International Research (International Collaborative Research)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 57:Oral science and related fields
• Research Institution: Chiba University
• Principal Investigator: 笠松 厚志 千葉大学, 医学(系)研究科(研究院), 准教授 (60375730)
• Project Period (FY): 2024-09-09 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2024)
• Budget Amount: ¥20,930,000 (Direct Cost: ¥16,100,000、Indirect Cost: ¥4,830,000); Fiscal Year 2026: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000); Fiscal Year 2025: ¥7,410,000 (Direct Cost: ¥5,700,000、Indirect Cost: ¥1,710,000); Fiscal Year 2024: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)